Related studies which point to total serum B12 as proof that high B12 levels drive cancer, are also misleading, as 80% of serum B12, on the second cobalamin carrier, haptocorrin, is not bio‐available, so that measuring total serum B12 is not helpful [101]. The gene discussed is TCN1; the disease is cancer.